Morgan Stanley Direct Lending Fund
NYSE:MSDLFinancial - Conglomerates
+$0.14 today
- Market cap
- $1.11B
- Beta
- 0.62
- P/E (TTM)
- 14.9
- EPS (TTM)
- $1.02
- Dividend yield
- 12.75%
Volume 0.45M
Average 0.67M
MSDL Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Morgan Stanley Direct Lending FundNYSE: MSDL
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 47.4% from a year ago
Cash & equivalents stood at $96.69M at the end of Q1 FY2026, up 47.4% from a year earlier and up 18.7% from the prior quarter. Over 3 fiscal years it compounded at +0.1% a year.
Context
- Cash & equivalents amounted to 2.5% of total assets at the end of Q1 FY2026, up 0.9 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +47.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 81.43M USD
- Year-over-year change
- +15.7%
- 4-year CAGR
- +2.4%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 81.43M | +15.7% |
| FY2024 | 2024-12-31 | 70.37M | +1.0% |
| FY2023 | 2023-12-31 | 69.71M | -14.2% |
| FY2022 | 2022-12-31 | 81.22M | +9.5% |
| FY2021 | 2021-12-31 | 74.15M | — |
Cash & Equivalents vs competitors
How MSDL compares with its peers on the latest reported figures
- Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +47.4% is the 2nd highest of 11, against a peer median of -18.1%.
- Cash & equivalents amounts to 2.5% of total assets for MSDL, versus a peer median of 1.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CN¥6.53B CNY | +20.7% | +19.5% | 25.5% | |
| Mar 2026 | CN¥5.67B CNY | -33.9% | -13.1% | 10.5% | |
| Sep 2026 | $349.1M USD | +35.9% | -30.3% | 1.7% | |
| Mar 2026 | $301.31M USD | -2.3% | +13.6% | 3.0% | |
| Sep 2026 | $104.8M USD | +39.1% | -6.5% | 1.1% | |
| Mar 2026 | $96.7M USD | -67.3% | +64.5% | 5.3% | |
| Mar 2026 | $96.69M USD | +47.4% | +0.1% | 2.5% | |
| Mar 2026 | $62.65M USD | -70.4% | -8.0% | 0.6% | |
| Jun 2026 | $17.88M USD | -97.2% | -58.8% | 0.1% | |
| Dec 2025 | $415.09K USD | +496.4% | +31.6% | 0.0% | |
| Dec 2025 | $49.91K USD | -81.4% | -57.3% | 0.0% | |
| Peer median (excluding MSDL) | — | -18.1% | -7.3% | 1.4% | |
Competitors are the stored peer set for MSDL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Morgan Stanley Direct Lending Fund
NYSE:MSDL
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.